HAIXI PHARMA(02637.HK)

Company Encyclopedia

HAIXI PHARMA

02637.HK

Fujian Haixi Pharmaceuticals Co., Ltd. manufactures and sells pharmaceutical drugs in China. The company offers drugs for oncology, ophthalmology, digestion, cardiovascular, endocrine, and nervous systems, and inflammation. It sells its products through retail pharmacies, online pharmacies, and internet medical platforms.

1.239 T

02637.HKMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update

PharmaceuticalsIndustry

Industry Ranking10/53

Industry medianC

Industry averageC

Score Analysis

Peer Comparison

Criteria
Rating
Profit ScoreA
- ROE16.58%A
- Profit Margin30.40%A
- Gross Margin83.38%A
Growth ScoreA
- Revenue YoY26.00%A
- Net Profit YoY31.35%B
- Total Assets YoY155.40%A
- Net Assets YoY207.75%A
Cash ScoreB
- Cash Flow Margin90.31%C
- OCF YoY26.00%A
Operating ScoreC
- Turnover0.45C
Debt ScoreA
- Gearing Ratio13.70%A

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
Xinshan Kang	16.2%	No Change	31/12/2025
Yan Feng	12.6%	No Change	31/12/2025
Xiamen Zhanhongda Investment Partnership (Limited Partnership)	9.65%	No Change	31/12/2025
Fujian Venture Investment Management Co., Ltd.	8.89%	No Change	31/12/2025
Xiamen Tairuihe Investment Management Partnership Enterprise (Limited Partnershi P)	6.35%	No Change	20/10/2025
Fuzhou Venture Capital Co., Ltd.	5.95%	No Change	31/12/2025
Xiamen Jindonghong Venture Capital Partnership (Limited Partnership)	5.7%	No Change	20/10/2025
Xiamen Jindongshi Venture Capital Partnership Enterprise (Limited Partnership)	4.99%	No Change	20/10/2025
Xiamen Huaxinyue Investment Partnership Enterprise (Limited Partnership)	3.95%	No Change	20/10/2025
Xinyu Hongrang Investment Management Partnership Enterprise (Limited Partnership)	3.57%	No Change	20/10/2025